Adaptimmune Therapeutics Plc ADR (NASDAQ:ADAP)’s traded shares stood at 0.39 million during the latest session, with the company’s beta value hitting 2.18. At the last
In the last trading session, 3.15 million Adaptimmune Therapeutics Plc ADR (NASDAQ:ADAP) shares changed hands as the company’s beta touched 2.17. With the company’s per
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
